Medesis Pharma SA
PAR:ALMDP

Watchlist Manager
Medesis Pharma SA Logo
Medesis Pharma SA
PAR:ALMDP
Watchlist
Price: 0.35 EUR Market Closed
Market Cap: €1.8m

Profitability Summary

Medesis Pharma SA's profitability score is 45/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

45 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

45 / 100
Profitability
Score
45 / 100
Profitability
Score

Margins

Earnings Waterfall
Medesis Pharma SA

Margins Comparison
Medesis Pharma SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FR
Medesis Pharma SA
PAR:ALMDP
1.8m EUR
Loading...
Loading...
Loading...
US
GE Vernova LLC
NYSE:GEV
265.7B USD
Loading...
Loading...
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
Loading...
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
Loading...
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
100.2B ZAR
Loading...
Loading...
Loading...
US
Schlumberger NV
NYSE:SLB
78.4B USD
Loading...
Loading...
Loading...
US
Fintech Ecosystem Development Corp
NASDAQ:FEXD
67B USD
Loading...
Loading...
Loading...
US
Baker Hughes Co
NASDAQ:BKR
59.3B USD
Loading...
Loading...
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
59.6B USD
Loading...
Loading...
Loading...
CH
Galderma Group AG
SIX:GALD
36.9B CHF
Loading...
Loading...
Loading...
US
Symbotic Inc
NASDAQ:SYM
35.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Medesis Pharma SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Medesis Pharma SA
PAR:ALMDP
1.8m EUR
Loading...
Loading...
Loading...
Loading...
US
GE Vernova LLC
NYSE:GEV
265.7B USD
Loading...
Loading...
Loading...
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
Loading...
Loading...
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
Loading...
Loading...
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
100.2B ZAR
Loading...
Loading...
Loading...
Loading...
US
Schlumberger NV
NYSE:SLB
78.4B USD
Loading...
Loading...
Loading...
Loading...
US
Fintech Ecosystem Development Corp
NASDAQ:FEXD
67B USD
Loading...
Loading...
Loading...
Loading...
US
Baker Hughes Co
NASDAQ:BKR
59.3B USD
Loading...
Loading...
Loading...
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
59.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Galderma Group AG
SIX:GALD
36.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Symbotic Inc
NASDAQ:SYM
35.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Medesis Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett